1 – 5 of 15
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
A novel endpoint for exacerbations in asthma to accelerate clinical development : A post-hoc analysis of randomised controlled trials
(
- Contribution to journal › Article
- 2016
-
Mark
Reduction of quality of life in prostate cancer patients : experience among 6200 men in the Nordic countries
(
- Contribution to journal › Article
- 2015
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
- 2013
-
Mark
Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra long-acting β2-adrenoceptor agonist (uLABA), with formoterol in patients with asthma.
(
- Contribution to journal › Article
- 2012
-
Mark
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.
2012) In Respiratory Medicine(
- Contribution to journal › Article